{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/immunizations-travel/background-information/other-diseases-requiring-vaccination/","result":{"pageContext":{"chapter":{"id":"041fa115-033d-5525-91ce-c43dbf593bd4","slug":"other-diseases-requiring-vaccination","fullItemName":"Other diseases requiring vaccination","depth":2,"htmlHeader":"<!-- begin field 9da3dce8-8e84-4b9c-8e6c-1c7eb4e29486 --><h2>Other diseases that may require vaccination</h2><!-- end field 9da3dce8-8e84-4b9c-8e6c-1c7eb4e29486 -->","summary":"","htmlStringContent":"<!-- begin item 8afe45a7-53c7-480f-a9da-da773a916b99 --><!-- begin field b5a4e838-875f-4582-9512-95275894a768 --><ul><li><strong>The following diseases are endemic in parts of the world, but do not usually pose a serious risk to most travellers overseas:</strong><ul><li>Cholera.</li><li>Hepatitis B.</li><li>Japanese encephalitis.</li><li>Rabies.</li><li>Tick-borne encephalitis.</li></ul></li><li><strong>In some specific circumstances, however, where there is an identified risk of contracting one or more of these diseases, vaccinations are available and may be recommended.</strong></li></ul><!-- end field b5a4e838-875f-4582-9512-95275894a768 --><!-- end item 8afe45a7-53c7-480f-a9da-da773a916b99 -->","topic":{"id":"8f89ca7f-a4f5-5e7d-80c8-de5db64ca7f0","topicId":"16d61716-d647-48bc-827b-b2b115ecd0fb","topicName":"Immunizations - travel","slug":"immunizations-travel","lastRevised":"Last revised in January 2021","chapters":[{"id":"25b90177-7e96-59db-b325-abc5f51c8721","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"bc7c22b0-dd64-50ad-8110-1fff4c8d6736","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"50f55046-7ca2-567f-94df-9c58f13770a5","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"2221cdd9-5576-5b5b-ad29-eff077930653","slug":"changes","fullItemName":"Changes"},{"id":"c755b06c-072d-5e60-be73-155dd664c37d","slug":"update","fullItemName":"Update"}]},{"id":"f5871d9a-dff3-59ce-a611-88d2ec41f5ce","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"513a86a0-e305-5e59-bd0d-1fb74a6e8689","slug":"goals","fullItemName":"Goals"},{"id":"87ea4699-bd41-5aeb-aa62-eac1fb591c4d","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"c8b054a0-ee87-5f9e-aa8f-c1fdf8442a29","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"a8eb4582-f05d-5af5-ae78-497260724f93","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"6f29b0b8-4b10-5e26-9ece-4cec050b1eb0","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"79cb1d1a-ebd1-58c6-9bc5-2bfd006c22c1","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"8d3187f5-2a99-5108-a7c9-dd601d729381","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"055aad08-f5af-5b2f-bda0-a35213a2a071","slug":"travel-vaccinations","fullItemName":"Travel vaccinations"},{"id":"c8d1352b-616b-5dff-9517-ea235b83e9d9","slug":"diseases-commonly-requiring-vaccination","fullItemName":"Diseases commonly requiring vaccination"},{"id":"041fa115-033d-5525-91ce-c43dbf593bd4","slug":"other-diseases-requiring-vaccination","fullItemName":"Other diseases requiring vaccination"},{"id":"1fe14ee1-a79f-565a-9380-ae3be597d7d5","slug":"where-these-diseases-are-prevalent","fullItemName":"Where these diseases are prevalent"},{"id":"68e09f74-2282-532f-ae34-064998823fc1","slug":"payment-for-travel-vaccinations","fullItemName":"Payment for travel vaccinations"}]},{"id":"0e45089d-2317-5ec5-8c73-f0709c003c48","fullItemName":"Management","slug":"management","subChapters":[{"id":"9c16c0cb-4e78-523d-914f-e884aea62565","slug":"initial-assessment-advice","fullItemName":"Scenario: Initial assessment and advice"},{"id":"f911dc04-ffd0-5a41-a3cb-b724797a7589","slug":"cholera","fullItemName":"Scenario: Cholera"},{"id":"422ff6d3-5810-5d3c-93b3-c5a67faaa0e1","slug":"hepatitis-a","fullItemName":"Scenario: Hepatitis A"},{"id":"01d49a70-70f4-547a-a551-ab524f99c944","slug":"hepatitis-b","fullItemName":"Scenario: Hepatitis B"},{"id":"5c77503c-2f59-5696-908b-125fe0e8e41c","slug":"japanese-encephalitis","fullItemName":"Scenario: Japanese encephalitis"},{"id":"8cb4ca86-fe31-5603-a75e-84413c2b5346","slug":"meningococcal-meningitis","fullItemName":"Scenario: Meningococcal meningitis"},{"id":"0e84be27-375b-55f5-9f51-d0e4cc422b58","slug":"poliomyelitis","fullItemName":"Scenario: Poliomyelitis"},{"id":"37a96f8b-4158-5e62-8e3d-6cedae506976","slug":"rabies","fullItemName":"Scenario: Rabies"},{"id":"8c237a0e-a760-55b2-b7b0-5383b7653be3","slug":"tetanus","fullItemName":"Scenario: Tetanus"},{"id":"85c90e1f-26f4-503b-b0b0-7c5a38930086","slug":"tick-borne-encephalitis","fullItemName":"Scenario: Tick-borne encephalitis"},{"id":"4e817d26-15f3-5ff7-a672-11caa36ffb68","slug":"typhoid-fever","fullItemName":"Scenario: Typhoid fever"},{"id":"5ec20606-2af2-556b-98a6-d8673a21a09d","slug":"yellow-fever","fullItemName":"Scenario: Yellow fever"},{"id":"e0a021ac-7c76-551a-97af-25341142d54f","slug":"hajj-umrah-pilgrims","fullItemName":"Scenario: Hajj and Umrah pilgrims"},{"id":"087d9fbb-1ec6-5f08-8e76-5df3a4a0b863","slug":"rapid-vaccination-courses-vaccination-at-short-notice","fullItemName":"Scenario: Rapid vaccination courses and vaccination at short notice"}]},{"id":"79dee816-dbdb-5426-8db3-2f095eedbff3","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"f1e9d43f-6815-516a-8511-3fd34a06525d","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"a69fb594-d4b4-56e6-b46a-6283ead93e30","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"52eea726-d50b-5e4f-a22c-764c1961119d","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"b2033c1b-25a2-5a58-b99e-00baf9b02a96","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"6df4842b-8812-534e-975d-52d29f3a8ee4","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"81e42472-4b49-5390-8179-0d131f547700","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"86482706-09b2-5113-bd4e-261c392f6483","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"8d3187f5-2a99-5108-a7c9-dd601d729381","slug":"background-information","fullItemName":"Background information"},"subChapters":[{"id":"c13bf8be-5ec4-54e9-a323-38bc1c593e74","slug":"cholera","fullItemName":"Cholera","depth":3,"htmlHeader":"<!-- begin field c6bdb97d-0a90-4baf-92ee-7421f885b047 --><h3>Cholera</h3><!-- end field c6bdb97d-0a90-4baf-92ee-7421f885b047 -->","summary":null,"htmlStringContent":"<!-- begin item 9595c0ab-d02b-4711-b371-c0bf24c09631 --><!-- begin field 75817bfd-78c1-4073-a49b-cc4c286c0bf6 --><ul><li><strong>Cholera is an acute illness </strong><strong>caused by the bacterium <em>Vibrio cholerae</em>.</strong><ul><li><em>V. cholerae</em> produces an enterotoxin that causes secretion of fluid and electrolytes, leading to painless, watery diarrhoea, and occasional vomiting.</li><li>The incubation period of cholera is usually 2–5 days, but the disease may become symptomatic in only a few hours.</li><li>In severe disease, dehydration, metabolic acidosis, and circulatory collapse may follow rapidly.<ul><li>Over 50% of the most severely affected people die within a few hours, while with prompt, effective treatment, mortality is less than 1%.</li></ul></li><li>Cholera is contracted via ingestion of faecally-contaminated water or food (especially shellfish) and via person-to-person spread.</li><li>Cholera is endemic in areas with poor sanitation and hygiene. The Indian subcontinent, the Far East, Africa, and South America are particularly affected. However, with adequate precautions (scrupulous personal, food, and water hygiene), the risk to the traveller is low.</li></ul></li><li>For more detailed information on cholera, see the <a href=\"https://www.gov.uk/government/collections/immunisation-against-infectious-disease-the-green-book#the-green-book\" data-hyperlink-id=\"054832b7-dbcf-4ab3-993a-a93100aaf7c3\">Department of Health</a> and <a href=\"https://travelhealthpro.org.uk/\" data-hyperlink-id=\"64c32b97-6698-4b35-8c58-a93100aaf809\">NaTHNaC</a> websites.</li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2013c</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">NaTHNaC, 2021h</a>]</p><!-- end field 75817bfd-78c1-4073-a49b-cc4c286c0bf6 --><!-- end item 9595c0ab-d02b-4711-b371-c0bf24c09631 -->","subChapters":[]},{"id":"13c842f4-30c2-5c89-b644-bec389bb3f4f","slug":"hepatitis-b","fullItemName":"Hepatitis B","depth":3,"htmlHeader":"<!-- begin field 8ddc8321-3bc9-447f-9fa2-8dbe913dbb71 --><h3>Hepatitis B</h3><!-- end field 8ddc8321-3bc9-447f-9fa2-8dbe913dbb71 -->","summary":null,"htmlStringContent":"<!-- begin item 235f77f6-872f-4777-8514-5f2f2fdd4476 --><!-- begin field 9579f6c6-edc0-4226-8d89-c40f640c8783 --><ul><li><strong>Hepatitis B is an infection of the liver caused by the hepatitis B virus (HBV).</strong><ul><li>The virus is transmitted by exposure to infected blood or body fluids, through vaginal or anal intercourse, blood-to-blood contact (e.g. sharing of needles and other equipment by injecting drug users, 'needlestick' injuries), perinatal transmission from mother to child, and bites from infected people (very rare).</li><li>The incubation period ranges from 40–160 days, with an average of 60–90 days.</li><li>The risk of hepatitis B for tourists is considered to be low but can be increased by participation in certain activities. For more information, see the section on <a class=\"topic-reference internal-reference\" href=\"/topics/immunizations-travel/management/hepatitis-b/#indications-for-vaccine\">Hepatitis B - indications for vaccine</a>.</li></ul></li><li>Many new infections with hepatitis B are subclinical or present as a flu-like illness.</li><li>Symptoms occur in only about 10% of younger children and in 30–50% of adults.</li><li>Acute infection may occasionally lead to fulminant hepatic necrosis, which is often fatal.</li><li>Infection can become chronic in a significant proportion of people. Chronic infection may lead to liver failure or liver cancer.<ul><li>The prevalence of chronic hepatitis B infection varies worldwide:<ul><li>In sub-Saharan Africa, most of Asia, and the western Pacific, more than 8% of people are chronically infected.</li><li>The Amazon, southern parts of Eastern and Central Europe, India, the Middle East, and the Indian sub-continent have a rate of chronic HBV infection of 2–8%.</li><li>In Australia, New Zealand, Northern and Western Europe, and North America, the prevalence of chronic hepatitis B viral infection is less than 2% of the general population.</li></ul></li></ul></li><li>See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/hepatitis-b/\">Hepatitis B</a> and the <a style=\"background-color: #ffffff;\" href=\"https://www.gov.uk/government/collections/immunisation-against-infectious-disease-the-green-book#the-green-book\" data-hyperlink-id=\"3b937c9f-a184-4c6a-ab8c-a93100a11c34\">Department of Health</a> and <a style=\"background-color: #ffffff;\" href=\"https://travelhealthpro.org.uk/\" data-hyperlink-id=\"2563dc6a-ec25-4b17-9e62-a93100a11c4b\">NaTHNaC</a> websites for more information.</li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2019</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">NaTHNaC, 2021i</a>]</p><!-- end field 9579f6c6-edc0-4226-8d89-c40f640c8783 --><!-- end item 235f77f6-872f-4777-8514-5f2f2fdd4476 -->","subChapters":[]},{"id":"cd7299b0-4c5f-5427-be98-73f32945683d","slug":"japanese-encephalitis","fullItemName":"Japanese encephalitis","depth":3,"htmlHeader":"<!-- begin field 2fe72c48-ba2b-4d6a-874a-0ea115c0cba9 --><h3>Japanese encephalitis</h3><!-- end field 2fe72c48-ba2b-4d6a-874a-0ea115c0cba9 -->","summary":null,"htmlStringContent":"<!-- begin item f7267e51-0a08-4f41-9f06-f00c8a052a6a --><!-- begin field 649d8c34-4f57-4266-bb90-f9f55866ea1f --><ul><li><strong>Japanese encephalitis (JE) is caused by a flavivirus that is spread by the bite of infected mosquitoes.</strong></li><li>Illness ranges from asymptomatic infection (it is estimated that only about 1 in 250 infections become clinically apparent) to severe encephalitis with high mortality and a high rate of permanent neurological sequelae (approximately 30%) in survivors.</li><li>JE has an incubation time of 5–15 days.</li><li>It is endemic in most of Asia, except Japan, Korea, Singapore, and Taiwan. It is particularly common in rural areas where pig farming and rice growing co-exist and is associated with the rainy season in some countries.</li><li>Reports in travellers are rare, and risk can be further minimized by employing mosquito bite-avoidance measures such as use of insecticides. </li><li>For more detailed information on JE, see the <a href=\"https://www.gov.uk/government/collections/immunisation-against-infectious-disease-the-green-book#the-green-book\" data-hyperlink-id=\"9cccdbd8-8249-466c-9a16-a93100a66d5d\">Department of Health</a> and <a href=\"https://travelhealthpro.org.uk/\" data-hyperlink-id=\"d79936ce-bd2c-4eec-bd31-a93100a66d8b\">NaTHNaC</a> websites.</li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2018a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">NaTHNaC, 2021j</a>]</p><!-- end field 649d8c34-4f57-4266-bb90-f9f55866ea1f --><!-- end item f7267e51-0a08-4f41-9f06-f00c8a052a6a -->","subChapters":[]},{"id":"962caf19-9199-54d5-a625-49d6a490f317","slug":"rabies","fullItemName":"Rabies","depth":3,"htmlHeader":"<!-- begin field 7e4844a3-32c9-4512-8e49-3d13a00dfda0 --><h3>Rabies</h3><!-- end field 7e4844a3-32c9-4512-8e49-3d13a00dfda0 -->","summary":null,"htmlStringContent":"<!-- begin item e9dff056-2956-4c84-93d2-3a2d4ece7178 --><!-- begin field 33f3df7e-0422-45ed-8966-78df06bd2e8e --><ul><li><strong>Rabies is an acute viral infection caused by a lyssavirus.</strong><ul><li>Transmission is generally via saliva from the bite or scratch of an infected animal (usually a dog).</li><li>The disease is preventable if the correct post-exposure prophylactic treatment is provided quickly.</li><li>The incubation period is generally 3–12 weeks but may range from 4 days to 19 years. In more than 93% of individuals, the onset is within 1 year of exposure.</li><li>Once symptoms are present, rabies is usually fatal, with death resulting from respiratory paralysis.</li><li>The rabies virus is endemic in most countries, and all continents of the world, except Antarctica, are affected. The principal carriers in Europe are thought to be foxes. In the United States, skunks, raccoons, and bats account for 95% of cases.</li></ul></li><li>For more detailed information on rabies, see the <a href=\"https://www.gov.uk/government/collections/immunisation-against-infectious-disease-the-green-book#the-green-book\" data-hyperlink-id=\"eefb251b-d485-4168-80f6-a93100a1c0a7\">Department of Health</a> and <a href=\"https://travelhealthpro.org.uk/\" data-hyperlink-id=\"5a62fecc-d68d-437a-9910-a93100a1c0b9\">NaTHNaC</a> websites.</li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2018b</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">NaTHNaC, 2021k</a>]</p><!-- end field 33f3df7e-0422-45ed-8966-78df06bd2e8e --><!-- end item e9dff056-2956-4c84-93d2-3a2d4ece7178 -->","subChapters":[]},{"id":"8eb99db8-116d-5451-9555-864e8c451a77","slug":"tick-borne-encephalitis","fullItemName":"Tick-borne encephalitis","depth":3,"htmlHeader":"<!-- begin field ffe63fe4-daec-40eb-bf27-20507e734147 --><h3>Tick-borne encephalitis</h3><!-- end field ffe63fe4-daec-40eb-bf27-20507e734147 -->","summary":null,"htmlStringContent":"<!-- begin item 6cc13436-2e69-4199-bf45-791619ecc000 --><!-- begin field b65600e8-713a-4bba-a93f-c80a3a7a757b --><ul><li><strong>Tick-borne encephalitis is caused by a flavivirus from the same family as yellow fever and Japanese encephalitis.</strong><ul><li>It is usually spread by tick bites, although unpasteurized milk is also thought to be a source of the disease.</li><li>The incubation period is 2–28 days following exposure.</li><li>It occurs in Austria, Germany, southern and central Sweden, France (Alsace region), Switzerland, Norway, Denmark, Poland, Croatia, Albania, the Baltic states (Estonia, Latvia, and Lithuania), the Czech and Slovak Republics, Hungary, Russia (including Siberia), Ukraine, some other countries of the former Soviet Union, and northern and eastern regions of China. Since the 1930s, tick-borne encephalitis has been a major public health problem in central Russia.</li><li>The disease has never been endemic in the UK.</li></ul></li><li><strong>There are three forms of the disease </strong>related to the virus subtypes, namely Western, Far Eastern, and Siberian.<ul><li>The European form of the disease is biphasic, with an initial viraemic phase of fever and influenza-like symptoms, followed in some cases (after an afebrile period of 1–20 days) by central nervous system involvement. The case fatality rate of the European form is 1–2%. Long-lasting or permanent neuropsychiatric sequelae occur in 10–20% of infected people.</li><li>The Far Eastern version is more gradual in onset and normally takes a more severe and longer course with a reported mortality of 5–20%.</li></ul></li><li>For more detailed information, see the <a href=\"https://www.gov.uk/government/collections/immunisation-against-infectious-disease-the-green-book#the-green-book\" data-hyperlink-id=\"38d80972-e8b4-425e-8f6b-a93100a1414e\">Department of Health</a> and <a href=\"https://travelhealthpro.org.uk/\" data-hyperlink-id=\"cadba9d9-6faa-4f78-ae95-a93100a14151\">NaTHNaC</a> websites.</li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2013d</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">NaTHNaC, 2021l</a>]</p><!-- end field b65600e8-713a-4bba-a93f-c80a3a7a757b --><!-- end item 6cc13436-2e69-4199-bf45-791619ecc000 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}